Project Grant R15DA059765
Award Date
9/1/24
Completion Date
8/31/27
Dollars Obligated
$421K
Federal Agency
National Institute on Drug Abuse
Federal Grant Program
93.279
Assistance Type
Project Grant
Place of Performance
Normandy, MO 63121, USA
Similar Awards
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $823,809 to the University of Pittsburgh to develop and validate a suite of multidimensional measures of access to Medications for Opioid Use Disorder (MOUD) across U.S. states and the District of Columbia. The primary objectives are to: Create a Small Area Multidimensional MOUD Access (SAMMA) measure suite using public data sources. Validate and...
The National Institute on Drug Abuse (NIDA) awarded a $267,696 Project Grant under CFDA 93.279 - Drug Use and Addiction Research Programs to the University of Massachusetts Lowell (UML), a minority-serving institution, for the project "Enhancing Opportunities for Addiction Research in the Merrimack Valley." The project aims to expand UML's existing Public Health Informatics and Technology (PHIT) program by creating a new PHIT-AR (Addiction Research) track. This will recruit diverse...
This $4.68 million project grant from the National Institute on Drug Abuse, part of the Department of Health and Human Services, will fund research under the Drug Abuse and Addiction Research Programs (CFDA 93.279). The University of Michigan will conduct a prospective cohort study of 400 adults with opioid-involved polysubstance use in Michigan. Researchers will collect detailed weekly data on participants' substance use patterns and motivations over four weeks to understand nuanced profiles...
This Project Grant award from the National Institute on Drug Abuse (NIDA), part of the NIH's Drug Use and Addiction Research Programs (CFDA 93.279), will fund a $751,043 research project at the University of Massachusetts Medical School focused on investigating the cellular and molecular mechanisms underlying the complex co-morbidity of opioid use disorder (OUD), major depressive disorder (MDD), and HIV in the human brain. The project will leverage single-cell sequencing technologies and other...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), is intended to design tailored harm reduction strategies to address the escalating drug overdose crisis in the United States. The $2,316,128 award, with a project period from September 15, 2024 to July 31, 2028, will support collaborative efforts with health departments and community partners across six jurisdictions (Rhode Island, Massachusetts, New York...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the federal Drug Use and Addiction Research Programs (CFDA 93.279), will support research to explore the unique neurobehavioral profile of sequential opioid-stimulant polysubstance use disorders. The $314,225 award, effective July 31, 2024 through February 28, 2025, will fund a study conducted by the University of Washington to: 1) Define the behavioral profile of dual opioid-methamphetamine use disorders in a...
This federal Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $187,164 to Temple University to conduct a mixed methods research study on the impact of "Institutions for Mental Diseases" (IMD) Medicaid waivers on the utilization of Medications for Opioid Use Disorder (MOUD). The 5-year study aims to: 1) Characterize the features of IMD waivers across jurisdictions, 2) Quantify the impact of...
This federal Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $218,900.00 to Rutgers, The State University of New Jersey to conduct research on characterizing the formation and maintenance of drug-biased beliefs in individuals with opioid use disorder (OUD). The key objectives are to: 1) quantify domain-specific optimism biases in OUD and re-assess these biases as participants engage with their...
This federal Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $194,098 to the University of Vermont & State Agricultural College to conduct research aimed at advancing the implementation of evidence-based treatments for stimulant use disorder (StimUD) and other substance use disorders (SUDs) in harm reduction and community treatment settings. The key objectives of the 5-year project are to: (1)...
This federal Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $2,134,928 to the Regents of the University of Minnesota to develop novel, brain-penetrant, small molecule biased allosteric modulators (BAMs) of the neurotensin receptor 1 (NTSR1) to attenuate relapse to opioid seeking in individuals with opioid use disorder (OUD). The research aims to validate NTSR1 as a drug target for OUD treatment...